PHOENIX, AZ--(Mar 26, 2012) - INSYS Therapeutics, Inc. (PINKSHEETS: NEOL) announces the launch of SUBSYS™ (fentanyl sublingual spray) indicated for the management of breakthrough pain in cancer ...
AUSTIN, TX—Sublingual fentanyl tablets were generally well tolerated in patients with cancer-related breakthrough pain aged 65 years and older in conjunction with around-the-clock opioid treatment, ...
Dissolvable film BNT23001 led to about 40% higher cladribine exposure than tablets in a preclinical pig study, BioNxt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results